The latest price target for Omega Healthcare Invts (NYSE:OHI) was reported by RBC Capital on November 11, 2024. The analyst firm set a price target for $43.00 expecting OHI to rise to within 12 months (a possible 6.67% upside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for Omega Healthcare Invts (NYSE:OHI) was provided by RBC Capital, and Omega Healthcare Invts maintained their sector perform rating.

The last upgrade for Omega Healthcare Investors Inc happened on March 22, 2024 when Citigroup raised their price target to $35. Citigroup previously had a neutral for Omega Healthcare Investors Inc.

The last downgrade for Omega Healthcare Investors Inc happened on January 16, 2024 when B of A Securities changed their price target from $33 to $31 for Omega Healthcare Investors Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Healthcare Invts, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Healthcare Invts was filed on November 11, 2024 so you should expect the next rating to be made available sometime around November 11, 2025.

While ratings are subjective and will change, the latest Omega Healthcare Invts (OHI) rating was a maintained with a price target of $39.00 to $43.00. The current price Omega Healthcare Invts (OHI) is trading at is $40.31, which is within the analyst’s predicted range.